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Abstract  
Managing pharmaceutical waste effectively can reduce risks to the environment and public health. 
In collaboration with the EDEN Center, an Albanian environmental NGO, our study assessed and analyzed 
the current pharmaceutical waste management system in Tirana. We interviewed ten percent of the over 
730 pharmacies in Tirana as well as other stakeholders to identify the current practices, challenges, and 
opportunities for improvement. Our study concluded that pharmacists would benefit from more 
information regarding laws, treatment companies, and their environmental impact. We also recommend 
additional incentives and regulations be implemented by the government, and a further study be 
conducted to expand upon our findings. 
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Executive Summary
Background 
Environmental Impact 
While pharmaceutical drugs have had profoundly 
positive effects, they have caused major environmental issues. 
Through improper disposal, medicines are found in water 
supplies in varying concentrations and pose risks to the 
environment and to human health. Antibiotics are among the 
most common and most harmful drugs found in the water 
supply. Though present in just trace levels, they allow bacteria to 
develop and spread antibiotic resistance, which makes bacterial 
infections more challenging to treat (Neu, 1992). Endocrine 
disruptors, like hormonal birth control, are also dangerous when 
leaked into the environment, especially for wildlife. The major 
dangers include developmental malformations, interference with 
reproduction, increased cancer risk, and disturbances in the 
immune and nervous system function (Norris, 2005; Gilbert, 
2011). 
Pharmaceutical Waste Management 
To reduce these risks, pharmaceutical waste must be 
sorted and specially treated in one of several ways. Popular 
methods include the use of lined landfills, incineration, return to 
the manufacturer for chemical recycling, or encapsulation in 
cement (World Health, 1999). Pharmacies often do not have the 
resources or expertise to achieve this independently, and thus 
contract with a treatment company (Smith, 2002). This treatment 
company is usually paid to remove and manage the waste 
properly.  
Pharmaceutical Waste Management in Albania 
As pharmaceutical waste management reform has been 
increasing globally, many organizations have undertaken the 
task of assessing and improving disposal practices in their own 
countries. This can be seen in Albania as well, with the research 
and initiatives developed by the Environmental Center for 
Development Education and Networking (EDEN Center, 2014). In 
2015, the EDEN Center completed a research document on the 
disposal of all medical waste across the country. In this study 
they found a significant lack of information concerning the 
disposal of pharmaceuticals (EDEN Center, 2016). After the 
report on medical waste was completed, the EDEN Center 
reached out to us for assistance in examining pharmaceutical 
waste management in the capital city of Tirana. 
Institutions for Pharmaceutical Distribution, 
Regulation, and Disposal  
The city of Tirana has 730 pharmacies, most of which are 
privately owned and very small, distributed amongst the 11 
administrative units. The districts that we focused on were Ish-
Blloku, the Center, and Ali Demi. These pharmacies are presided 
over by the Order of the Pharmacists, the Ministry of Health, the 
Ministry of Environment, and many smaller governmental 
bodies. The Council of Ministers is the primary legislative body 
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that established the required disposal practices of pharmacies. 
These laws state that pharmaceutical waste must be destroyed 
by an organization with the proper environmental license (For 
Hazardous Waste Management, Chapter 4 Articles 12-13, 2006). 
Therefore the pharmacies must contract with a treatment 
company to dispose of their waste. 
There are a few private treatment companies that have 
the certification from the government to handle the treatment of 
pharmaceutical wastes. Unfortunately there have been some 
scandals involving these waste removal companies, where some 
have been implicated in dumping waste into the environment 
rather than treating it correctly (Fraud, 2015). These actions have 
weakened the credibility of treatment companies and 
discouraged pharmacies from working with them. Alternatively, 
pharmacies can give their waste to the National Center for Drug 
Control, which then contracts with a treatment company to 
handle the waste from various pharmacies. 
There was limited information in the literature regarding 
reasons why pharmacies may not obtain contracts to manage 
their waste. Possibilities we considered included:  avoiding 
disposal costs; lack of training or knowledge; and distrust in the 
treatment companies. However, no relationship has been 
established between any of these factors and the practices of 
pharmaceutical waste disposal in Tirana. Our research attempted 
to fill the gaps in the current understanding of these causes. 
 
 
Objectives 
 Assess the current practices and policies for 
pharmaceutical waste management in Tirana; 
 Uncover the challenges that are preventing effective 
pharmaceutical waste management; 
 Identify stakeholders’ roles and perspectives in the 
pharmaceutical waste management system; 
 Demonstrate the need for more information on the 
subject of pharmaceutical waste management; 
Methods 
        We examined the practices of approximately 10% of the 
pharmacies in Tirana using a structured questionnaire with both 
closed and open ended questions. Pharmacies were interviewed 
in three of the eleven administrative units of Tirana, whose 
different locations and demographics were analyzed for their 
effects on the practices of the pharmacies. These respondents 
were fully informed that all of their answers would be kept 
completely confidential and that the information gathered was 
only intended to improve the waste management system. We 
used a multi-method approach consisting of interviews with the 
assistance of volunteer translators, direct subject observations, 
and the analysis of government and private records. The most 
important interview questions asked were: 
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 Does this pharmacy produce pharmaceutical waste, and 
if so, how much? 
 Does this pharmacy have a contract with a treatment 
company? 
 How often does the Ministry of Health Inspector visit this 
pharmacy? 
 What challenges do you face with pharmaceutical waste 
disposal, and what recommendations do you have to 
improve the system in place? 
        We used inductive thematic analysis in order to come up 
with trends from the data that we found (Berg, 2004). 
Additionally, we analyzed the associations between the 
responses and factors such as location, traffic level, and 
inspection frequency. 
        Similar interviews were conducted with other 
stakeholders in the pharmaceutical waste management system, 
including distributors, Ministry officials, and treatment company 
representatives, to provide a more complete picture. 
        The responses from the pharmacists and the 
stakeholders together demonstrated the current practices and 
challenges in the pharmaceutical waste management system, as 
well as revealing the feasible opportunities for improvement. 
 
Results 
Current pharmaceutical waste disposal practices 
and their causes 
Our study approached 74 pharmacies, approximately 
10% of those in Tirana, of which almost 20% of pharmacies 
declined to participate in our study. There were a variety of 
explanations for their refusals. Responses we received include: 
pharmacists feeling they were successful and felt our study was 
not necessary, pharmacies having opened in the last few days, 
pharmacists telling us that they were too busy, and responding 
with anger. Of the pharmacies that were interviewed, about 70% 
acknowledged that they produce pharmaceutical waste, but 
most claimed to only produce small amounts of waste. While 
their interpretations of “small” varied, most pharmacists used this 
as a justification for not having a contract. The remaining 
pharmacists that claimed they did not produce pharmaceutical 
waste occasionally explained that they buy in very small 
quantities or reduce prices as medications approach their 
expiration. 
Over half of the pharmacies interviewed admitted to not 
having a contract with a treatment company. This was attributed 
to several different factors. Obtaining contact information for the 
treatment companies was a significant barrier, as was a lack of 
trust in their disposal practices. Our study also concluded that 
the cost of a contract with a treatment can be prohibitive for a 
small pharmacy. The small size of the pharmacies makes them 
less likely to comply with the law. These pharmacies perceived 
their amount of waste as being inconsequential, and may have 
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Figure 1: Frequency of Inspection Visits 
had difficulty appreciating the impact of waste from all the 
pharmacies combined. 
Interviewed pharmacists were also asked how often they 
are visited by an inspector from the Ministry of Health. We found 
that answers varied greatly, though the median number of visits 
was once annually. A correlation can be observed that 
pharmacies which receive more frequent inspection visits are 
more likely to have a contract and comply with the law. It is 
difficult for the pharmacists to rely on an enforcement system 
that is not consistent.  This can be viewed in Figure 1 below.  
Challenges expressed by pharmacists 
Pharmacists were especially varied in their willingness to 
express their difficulties and offer recommendations. Some were 
dismissive, expressing that they did not need any help, while 
others were willing to explain their struggles at length. 
Many pharmacists felt that the cost of disposing of 
pharmaceutical waste properly was a significant disincentive. 
Pharmacists expressed that they could not pay for the waste 
removal, since the expired medication already represented a loss 
of income. Many did not want to pay annual fees due to their 
small waste production levels. The pharmacies in our study were 
small and over 90% were independently owned, rather than 
being a part of a chain, which reduces their capital resources. 
Further, the control of the wholesale price by the Ministry limits 
flexibility in pharmacy budgets. Therefore, many pharmacists 
seemed justified in saying that they did not have a contract due 
to its price. 
 We found that pharmacists were lacking information 
about the laws and regulations that they must be following, 
which makes it very hard for them to comply. We received many 
different answers from the pharmacists about the laws. Over a 
third of all pharmacists that were interviewed claimed that they 
were confused or lacked knowledge about the laws and 
regulations regarding pharmaceutical waste. Other pharmacists 
claimed they knew and followed the law. In both cases, we 
found that not all of pharmacists were following the laws. It 
seemed that they were not all provided with the same 
information and the information they did have was not always 
clear to them. Therefore, many pharmacists would appreciate 
more guidance, information, and assistance from their 
government.  
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Recommendations 
Access to Information 
The most pervasive issue observed was the sparse and 
inconsistent information pharmacists had been provided about 
the laws they are expected to adhere to, the treatment 
companies they can contact, and the impact of improper 
disposal on the environment. Pharmacists would benefit from 
information in a simple and clear format, with updates as 
information changes. It would be important to include the 
current laws regarding pharmaceutical waste disposal, contact 
information for available treatment companies, and an 
explanation of the environmental impact of improper disposal, 
even in small quantities. 
Ministry of Health Controls 
Our research study found that frequent and regular visits 
from a Ministry of Health inspector are associated with a greater 
percentage of pharmacies having contracts and following the 
law. Increasing oversight may make pharmacists more aware of 
the consequences for not complying. In addition, it could 
provide an opportunity for the pharmacists to ask any questions 
they may have regarding the laws or treatment companies. 
Incentives for Proper Waste Disposal 
Many pharmacists expressed that they would be 
motivated by various incentives the government could offer. 
These could include financial reimbursements, tax cuts, or even 
the opportunity to advertise to customers that their pharmacy is 
environmentally friendly. 
Further Investigation 
The data that we collected was highly variable, and our 
results generated many additional questions about the current 
system. A study with greater resources will be better able to 
investigate all of the stakeholders involved, including the 
perspective of the government, and extend the study to 
pharmacies across Albania.  
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Chapter 1: Introduction 
Steep growth in the pharmaceutical 
industry over the last several decades has 
led not only to more medications on the 
market but also to a significant 
environmental and public health hazard 
when these drugs are not disposed of 
properly. Pharmaceutical drugs are 
classified as any “natural or chemical 
substances used for treating, curing and 
preventing different types of diseases” 
(Pharmaceutical Drugs, 2009). If not 
handled and disposed of properly, 
pharmaceutical waste can ultimately enter 
water bodies, including drinking water 
sources, through sewer lines and as 
effluent from landfills. This can lead to 
public health and ecological risks, such as 
antibiotic resistance in bacteria (Neu, 1992). 
There has been a significant global 
effort to prevent pharmaceutical waste 
from polluting the environment. Though 
the types of waste are varied, when they 
are properly collected and sorted, there 
are several safe ways to discard of 
pharmaceutical waste (World Health, 1999). 
Pharmacies in the United States and 
elsewhere often contract with treatment 
companies to manage their 
pharmaceutical waste, as the pharmacists 
themselves are not always given training 
about the disposal regulations (Smith, 
2002). However, current research suggests 
that Albanian pharmacies are not utilizing 
treatment companies, and may not be 
disposing of their waste properly (EDEN, 
2016). Though regulations are in place in 
Albania regarding pharmaceutical waste 
disposal practices (For Pharmaceutical 
Drugs and Service, 2014), research 
suggests that many pharmacies do not 
consistently follow regulations (Hoxha, 
Malaj, Tako, & Malaj, 2015). The first step in 
developing effective policies for the 
treatment of pharmaceutical waste is 
gaining a better understanding of the 
reasons why pharmacies are not 
complying with the regulations (Tong, 
Peake & Braund, 2011). 
Our sponsor, The Environmental 
Center for Development Education and 
Networking (EDEN Center) wants to assess 
and improve pharmaceutical waste 
disposal practices in Albania. From 2014 to 
2015, the EDEN Center performed a study 
in five cities in Albania that was aimed at 
providing information regarding the gaps 
in the chain of health care waste 
management in Albania. By interviewing 
manufacturing and treatment operators as 
well as healthcare waste inspectors, this 
study highlighted a lack of information on 
the disposal practices of pharmacies. They 
have therefore asked us to conduct a study 
to learn how and why pharmacies dispose 
of their pharmaceutical waste. This study 
will demonstrate the need for a larger 
study of pharmaceutical waste 
management practices in pharmacies 
across Albania.  
While in Tirana we examined the 
drug disposal practices of pharmacies in 
several different neighborhoods of the city. 
We interviewed pharmacy owners and 
pharmacists, as well as pharmaceutical 
suppliers, treatment companies, and public 
health officials. This illuminated the varied 
perspectives about the challenges and 
opportunities for safer disposal of out of 
date and unused medicines. 
Understanding these challenges will be 
critical to developing solutions for safer 
pharmaceutical waste disposal practices in 
Albania.  
  
Chapter 2: Background   
  
The purpose of this chapter is to examine the current literature regarding pharmaceutical waste, global management efforts, the challenges 
they face, and the applications to Tirana, Albania. In section 2.1, we discuss the various effects that pharmaceuticals have on the environment. When 
antibiotics get into the water, they can cause antibiotic-resistant bacteria, and steroids can affect the messenger hormones in animals exposed to the 
water. Section 2.2 focuses around the methods that can be implemented in order to properly dispose of the pharmaceutical wastes. Section 2.3 will 
center around the impacts of medications that are discarded into public waste streams. In section 2.4, we discuss the EDEN Center and its mission to 
promote awareness of environmental issues. The use of pharmaceuticals as well as the issue of self-medication in Albania is explained in section 2.5. In 
section 2.6, the laws and regulations on the distribution and disposal of pharmaceutical drugs are evaluated. Finally in section 2.7, we discuss the 
regulations and challenges that Albania faces when it comes to the disposal of pharmaceutical waste. 
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Figure 1: The progression of antibiotic resistance 
(BioLegend, 2015) 
2.1 Environmental Effects of Pharmaceuticals 
While pharmaceutical drugs have 
had profoundly positive effects, they have 
caused major environmental problems. 
Through improper disposal the drugs have 
found their way into the water supply, and 
this has many negative side effects, not all 
of which are fully understood. In most 
water supplies, pharmaceutical residues 
are detected at trace levels, but even low 
concentration levels, between 1 part per 
trillion and 1 part per billion, can have toxic 
effects. Antibiotics are among the most 
common drugs found in the water supply. 
These drugs are particularly dangerous; 
they cannot kill bacteria in such low 
concentrations, but create more resistant 
bacteria. Any individual bacterium that has 
this resistance can transmit it to other 
bacteria. Antibiotic resistant bacteria have 
to be treated with less commonly used 
antibiotics, which can be impossible in 
areas where full medical care is not 
available. There have even been 
documented cases of “superbugs” that 
have become resistant to all of the 
regularly used antibiotic medicines (Neu, 
1992). According to the Center for Disease 
Control, 2 million Americans were infected 
by bacteria with antibiotic resistance in 
2013. Of those infected, twenty-three 
thousand died from the infection (Centres 
for Disease Control and Prevention, 2013). 
Without the ability to quickly and 
effectively treat bacterial infections those 
patients who are most vulnerable will be in 
serious danger. These patients include 
those undergoing chemotherapy for 
cancer and dialysis for renal failure, 
children, the elderly, and those recovering 
from surgery, especially organ 
transplantation. These types of infections 
are even more dangerous for those 
countries that do not have sophisticated 
medical treatment centers where sterile 
protocol is not followed as often.  
The other major group of drugs that 
is having profoundly negative effects on 
the environment is steroids. Steroids are a 
group of medications that contain a 
particular carbon ring backbone made of 
three cyclohexane rings and one 
cyclopentane ring (Tyler, 1998). The 
hormones naturally found in every animal 
share this same base structure. Steroids 
can enter animals without being acutely 
toxic; however, they can mimic or inhibit 
the actions of the internal messenger 
hormones, especially those that compose 
the endocrine system. The endocrine 
system is the collection of glands that 
produce hormones that regulate 
metabolism, growth and development, 
tissue function, sexual function, 
reproduction, sleep, and mood, among 
other things, making endocrine disruption 
extremely dangerous (Norris, 2005). The 
major dangers include developmental 
malformations, interference with 
reproduction, increased cancer risk, and 
disturbances in the immune and nervous 
system function. Amphibians have been 
shown to be particularly affected by these 
Chapter 2: Background 
  
drugs. Birth defects have become common 
in many species of frogs (Norris, 2005). 
One example of extreme endocrine 
disruption was documented in a French 
study of fish near a pharmaceutical 
production plant. The levels of endocrine 
disrupting molecules, specifically those 
found in birth control pills, reached a level 
high enough to affect the physiology of 
the Gudgeon fish being studied. 
“Downstream from the factory, the 
researchers found that on average 60% of 
the fish had both male and female sexual 
characteristics” (Gilbert, 2011, pg. 1), as 
compared to only 5% upstream of the 
factory. This clearly shows that the drugs 
being allowed to enter the river were 
seriously affecting the fish through 
endocrine disruption. The scientists 
recorded the concentration of 
dexamethasone at the extremely high level 
of over 10 micrograms per liter. Both of 
these environmental problems are 
consequences of improper disposal of 
pharmaceuticals. These environmental 
dangers can be prevented with a proper 
disposal system.  
2.2 Global Pharmaceutical 
Waste Management 
Though there are many dangers 
associated with pharmaceutical waste, it 
can be properly and safely treated. The 
simplest method is to dispose of the waste 
in a landfill, though it has the potential to 
be very dangerous. Using a landfill for 
pharmaceutical waste management should 
always be the last resort because of its 
likelihood to allow pharmaceuticals to 
enter waterways through runoff and thus 
impact the environment. Using landfills for 
medical waste is only safe when they are 
located far away from bodies of water, or 
are specially lined to contain hazardous 
waste. Most landfills used today are 
designed to contain household waste, not 
to prevent pharmaceutical waste from 
leaching out into the water supply.  
It can often be safer to return the 
pharmaceutical waste to the original 
manufacturer. If they are properly 
separated and not yet expired, these drugs 
even have the potential to be reused by 
the manufacturer with proper chemical 
purification. The problem arises when the 
pharmaceuticals are expired, because they 
are then classified as hazardous waste. 
Most pharmaceuticals that would be 
returned to the manufacturer or donor are 
expired and therefore cannot be resold 
without extensive chemical treatment. 
Specific procedures must be followed 
whenever hazardous waste is transported 
internationally. These procedures require 
significant investments of time and money 
(World Health, 1999). The manufacturers or 
donors that take back their 
Figure 2: A deformed leopard frog metamorph found 
near Lake Champlain in Vermont (Zimmer, 2011) 
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Method Safety Ease Cost 
Landfill High possibility to leak 
into waterways 
Easiest method N/A 
Returning to 
Original 
Source 
Depends on the source 
and how they dispose of 
the pharmaceuticals 
Can be difficult if 
pharmaceuticals are 
expired and travel 
internationally 
N/A 
Incineration Possibility for toxic 
gaseous by products 
Access to able facilities 
is difficult 
>US $2.2/kg - 
US $4.1/kg 
Encapsulation Can handle all types of 
pharmaceuticals in both 
solid and liquid states 
Can send to an 
encapsulating company 
or use a machine 
Machines can 
be purchased 
to complete 
this task 
Information that inspired this table was compiled from World Health, 1999 
pharmaceuticals would dispose of them 
using the other described methods. 
A less complex method for 
pharmaceutical waste management is 
incineration. Incineration is the process of 
burning the pharmaceuticals at 
temperatures upwards of 1,200°C. This 
method’s major benefit is that the 
pharmaceutical is prevented from entering 
the water supply. However, incineration 
can be a costly disposal method. In 1999 
the World Health Organization estimated 
the cost of incineration in the 
Northwestern Balkans to range from US 
$2.2/kg to US $4.1/kg. Though inflation has 
certainly increased this value since 1999, 
incinerating the entire stockpile of 
pharmaceuticals in Croatia, for example, 
would have cost between US $4.4 million 
and US $8.2 million (World Health, 1999). 
Another point of concern when burning 
pharmaceuticals is the possibility that toxic 
gases are produced and released into the 
environment. These toxic fumes can be 
absorbed into substances like activated 
carbon or cement clinker product to 
prevent them from damaging the 
atmosphere (World Health, 1999). Another 
method of disposal is encapsulation. 
Encapsulation is the practice of partially 
filling a plastic or steel drum with 
pharmaceuticals and then completely 
filling it with concrete or other similar 
substances in order to prevent the 
chemicals from leaching out into the 
environment (World Health, 1999). Table 1 
to the left summarizes the pharmaceutical 
waste management methods as described 
above. 
2.3 Pharmaceutical Waste 
Management Practices in 
Pharmacies 
Pharmacies play a large role in the 
disposal of pharmaceutical waste by 
properly collecting and sending waste to 
appropriate disposal facilities. Pharmacies 
are a crucial location for proper collection 
and disposal because in addition to 
producing their own expired medicines 
when overstocked, some even buy back 
expired medications from consumers 
(Seehusen & Edwards, 2006). There is a 
significant amount of legislation 
surrounding pharmaceutical waste disposal 
by pharmacies in the United States, 
including the Resource Conservation and 
Table 1: Pharmaceutical Waste Management Methods 
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Recovery Act, enforced by the EPA (Smith, 
2002), as well as various other rules from 
the U.S. Food and Drug Administration 
(FDA), the Drug Enforcement 
Administration (DEA), and many more 
(Stericycle Environmental Solutions, 2016). 
While pharmacies could manage some of 
these regulations on their own by sorting 
their waste and disposing of it accordingly, 
“pharmacists do not routinely receive 
instruction in environmental regulations,” 
making this process more difficult (Smith, 
2002, pg 17). However, Figure 4 on the 
following page from Smith (2002) shows a 
suggested system for pharmacies to use. 
To simplify this process, some 
countries have developed alternative 
systems. In the city of Novi Sad, Serbia, 
pharmacies can dispose of their waste at 
transfer stations; these transfer stations are 
also open to the public. The Serbian Prime 
Minister is trying to convince the rest of 
the country to adopt these transfer 
stations and mimic Novi Sad. The 
pharmaceutical waste is collected and then 
disposed of it in a safe manner, most 
commonly incineration (Milutinovic, V., & 
Trumbulovic, L, 2014). 
As an alternative, many pharmacies utilize 
a pharmaceutical waste disposal company 
like Stericycle Environmental Solutions. 
This is only one of many companies in the 
US, yet they dispose of over 336 thousand 
tons of pharmaceutical waste annually 
(Stericycle Environmental Solutions, 2016). 
This practice is common in many nations 
across the globe, as one survey in New 
Zealand published that “80.4% and 61.1% 
[of pharmacies] respectively reported that 
solid and semi-solid medications were 
removed by contractors,” which was 
regarded as an “appropriate and viable 
method” (Tong et al, 2011, pg 197, 201). The 
use of these programs is therefore 
encouraged as the simplest and most 
effective method, especially when the 
pharmacists have limited access to training 
regarding proper pharmaceutical waste 
disposal (Smith, 2002). However, this 
method is expensive for the pharmacy 
because they must pay a yearly fee to use 
the treatment company, and some 
additionally charge by weight. Whichever 
method is chosen, however, pharmacies 
and their disposal practices play a crucial 
role in the pharmaceutical waste 
management system.  
Figure 3: Correct Pharmaceutical Waste Pathway 
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Figure 4: Recommended Pharmaceutical Waste Streams (Smith, 2002) 
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2.4 Environmental Center for 
Development Education and 
Networking 
As pharmaceutical waste 
management reform has been increasing 
globally, many organizations have 
undertaken the task of assessing and 
improving disposal practices in their own 
countries. This can be seen in Albania as 
well, with the research and initiatives 
developed by the Environmental Center for 
Development Education and Networking 
(EDEN Center, 2014). The EDEN Center has 
become one of the most active non-profit 
and non-politically oriented organizations 
in Albania since its establishment in 2004 
(EDEN Center, 2014). The mission of the 
EDEN Center is to promote sustainable 
environmental practices through education 
of the public and collaboration with other 
organizations. The EDEN Center’s major 
funding comes from its donors, including 
the EU Commission, the Global 
Environment Fund, UNICEF, the World 
Health Organization, the CEE Bankwatch 
Network, and the American Embassy. From 
2014 to 2015, the EDEN Center completed 
a research document on the disposal of all 
medical waste across the country. In this 
report they found a significant lack of 
information concerning the disposal of 
pharmaceuticals (EDEN Center, 2016). After 
the report on medical waste was 
completed, the EDEN Center reached out 
to the WPI Albanian Project Center to 
recruit assistance to examine 
pharmaceutical waste management in the 
capital city of Tirana.  
2.5 Pharmaceutical Use in 
Albania 
Pharmaceutical waste management 
is an issue of particular importance in 
Albania, as many factors have contributed 
to a large accumulation of expired 
pharmaceutical waste. One factor for this 
continuously growing stockpile is the 
recent expansion of the pharmaceutical 
industry in Albania. Compared to other 
countries in Europe, including Serbia, 
Slovakia, and Poland, Albania has spent a 
higher percentage of its total healthcare 
expenditure on pharmaceuticals over the 
last two decades, recorded at 25% in 1999 
(Mossialos, Walley, & Mrazek, 2004). In 
recent years this percentage has risen 
considerably, to 35% and 55% in 2013 and 
2015 respectively (Ministry of Health, 2016). 
These percentages only represent an 
increase in the purchases of 
pharmaceuticals as opposed to other 
curative measures. The Ministry of Health 
has not released the growth in the 
pharmaceutical industry in any absolute 
values. However, an absolute increase can 
be proven as there has been data 
published for the growth of the GDP in 
Albania. The percentage of the healthcare 
expenditure that contributes to the 
pharmaceutical industry is increasing; the 
percentage of the GDP allocated to 
healthcare has been generally increasing 
(World Bank, 2016; Memaj & Duka, 2008); 
the GDP has been relatively steady (World 
Bank, 2016). A graphic of the increase in 
the absolute pharmaceutical expenditure 
can be found on the following page.  
Figure 5: EDEN Center Logo (2016) 
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Figure 6: Absolute Albanian Pharmaceutical Expenditure Compiled from Data from the World Bank (2016), the Ministry of Health (2016), and Mossialos, et al (2004) 
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This collectively suggests a massive 
expansion of the pharmaceutical industry 
in Albania. In the past two years, 671 new 
drugs have been registered with the 
Ministry of Health, which is approximately 
one for every working day. These drugs 
are becoming cheaper as well, making 
them even more popular with consumers. 
In September 2016, the Minister of Health, 
Ilir Beqaj, claimed in a media outlet that 
the previous year (2015) had seen 48.2 
million pharmaceutical purchases, which 
represented a 17.5% increase from the 41 
million in 2012 (Ministry of Health, 2016). 
48.2 million purchases would suggest a 
rate of 16.6 prescriptions (or what should 
have been prescriptions) per person per 
year, compared to 12.7 in the US (The 
Henry J Kaiser Family Foundation, 2016). 
This suggests a greater number of 
pharmaceuticals that must be produced in 
or imported into Albania. It could be 
reasonably assumed that the increase in 
pharmaceutical medications sold and used 
will cause a corresponding increase in the 
amount of pharmaceutical waste. 
There is reason to believe that many 
of these pharmaceuticals will be allowed to 
expire as many Albanian consumers are 
purchasing unnecessary antibiotics. As 
previously noted, antibiotics can pose risks 
to the environment when overused and 
especially when improperly discarded. In 
many countries, this is addressed with 
regulations to reduce the number of 
prescriptions for antibiotics written by 
practitioners (Slomski, 2016; McIsaac, 
1998; Ranji, 2008). Such regulations may 
be needed in Albania, as rates of 
prescribing are quite high, with 66% of 
urban and 74% of rural visits to a general 
practitioner resulting in a prescription, 
according to a 2006 survey (Fournier, 
Tourigny, Ylli, Nuri, & Haddad).  
However, it is common for Albanians 
to self-medicate using antibiotics, 
weakening the efficacy of regulating 
antibiotics with prescriptions. Self-
medication is the act of using medication 
to treat common illnesses or health 
problems, and many people will self-
medicate in order to avoid a costly medical 
bill or because they believe that they know 
how to make themselves better. A 
questionnaire was given out in 2014 (Jorgji, 
Bebeci, Apostoli, & Apostoli) to 350 young 
people who visited 10 different pharmacies 
in Tirana. The results of this survey showed 
that nearly 80% of those surveyed self-
medicated with antibiotics, which was 
correlated with responses that reported 
low and medium levels of education. Jorgji 
et. al. specifically found that people most 
commonly used amoxicillin as an antibiotic 
when they were self-medicating. This 
practice of self-medication is enabled by 
the pharmacies, of which reportedly 80% 
are willing to give out amoxicillin without a 
prescription, according to a 2015 survey 
(Hoxha et al). Amoxicillin is not considered 
an over the counter medication by the 
Albanian Ministry of Health (Cikuli, 2007), 
suggesting that this is a cultural issue 
rather than a legislative one. Both the 
consumers and the pharmacists currently 
seem willing to utilize and distribute 
antibiotics without definite cause, likely 
due to a lack of knowledge about the 
dangers associated. Without the 
consultation of a physician, patients are 
more likely to be unaware that antibiotic 
Figure 7: Results of Hoxha et al 2015 Survey 
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courses should be completed and may 
stop taking the drugs once they feel better. 
These excessive antibiotics may then be 
left to expire, or disposed of improperly 
within the home.  
Finally, pharmaceuticals that were 
donated to Albania to support Kosovo 
refugees in 1999 currently represent a 
large source of expired waste. At the time, 
The Health Insurance Scheme covered an 
estimated 70% of the population, and 
further the tate covered only 20% of 
required drugs and medical supplies in 
hospitals. The influx of Kosovo refugees 
put even further strain on the healthcare 
sector. As a result, the international 
community made every effort to assist 
during this crisis and donated several tons 
of pharmaceutical drugs to Albania. These 
donations were audited by the World 
Health Organization, and it was found that 
easily 50% would be useless and eventually 
require disposal (Watson, 1999). Over 40% 
had no mention of an expiry date, another 
40% reportedly had less than a year before 
their expiration date, and as much as 80% 
of the medications that were donated were 
not requested by Albania. Many of the 
companies that donated were trying to get 
rid of old and expired medications. They 
also had the incentive of getting tax write-
offs by “donating” the medicines to a 
country in need (“Drug Donations,” 1999). 
This led to an enormous stockpile of 
unused and expired drugs, with Albania 
bearing the financial burden of disposal. 
Currently there is no evidence to suggest 
that these extensive stockpiles have been 
properly disposed of over the last two 
decades, and Albania currently lacks the 
infrastructure to do so. Combined, these 
factors suggest that Albania would benefit 
greatly from a system to properly dispose 
of expired and unused pharmaceuticals.  
Figure 8: Refugees from Kosovo Coming into Albania (FilmAid International, 2015) 
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2.6 Institutions for Pharmaceutical Distribution, Regulation and Disposal 
The city of Tirana has 730 
pharmacies, most of which are privately 
owned and very small, distributed amongst 
the 11 administrative units. There is a 
constant flux in the location and number of 
pharmacies in Tirana. The districts that we 
focused on were Ish-Blloku, Qendra, and 
Ali Demi, located respectively in the south-
central, central, and eastern sections of 
Tirana. We used “Ish-Blloku” to refer to a 
section of Administrative Unit 5, which 
contains the neighborhoods Ish-Blloku and 
Tirana e Re. Ish-Blloku was once the home 
to many political leaders during the 
communist era of Albania. Since 
communism ended, this area has become 
a wealthier part of Tirana (Williams, 2014). 
This has allowed the pharmaceutical 
market to thrive in this neighborhood 
because people can afford to pay for the 
medications. We used “Qendra,” the 
Albanian word for center, to refer to parts 
of Administrative Units 10 and 7, including 
the neighborhoods 21 Dhjetori, Rruga 
Bouojës, Rruga Durrësit, and Rruga 
Myslym Shyr. Qendra is the busiest part of 
Tirana, and it was expected to therefore be 
more controlled than other areas. By 
comparison, Ali Demi, which is a part of 
Administrative Unit 1, is less central to the 
city of Tirana, and has somewhat less 
prosperous customers frequenting their 
pharmacies.  
Figure 9: Map of Administrative Units (2016) 
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All pharmacies in Tirana are subject 
to regulations set by the Ministry of Health, 
the Ministry of the Environment, and 
several other institutions. One of these 
institutions is the Order of Pharmacists 
(UFSH)1, which is a professional 
                                                 
 
1
 In Albanian, Urdhri i Farmacisteve te 
Shqiperise 
organization that presides over the 
pharmacies to assist in regulations. The 
UFSH is a public entity that is composed of 
pharmacists that "represents their 
professional interests at the level of 
institutional partnership" (On the Order of 
Pharmacists in the Republic of Albania, 
2003, page 36). This organization was 
created to unite the pharmacists and to 
protect them, by ensuring that they are 
properly trained and enforcing the norms 
of medical ethics. The UFSH sets an ethical 
and professional standard, which the 
pharmacist must uphold, as well as the 
standards for their education. This 
organization keeps a record of all the 
pharmacists in Albania, partially due to the 
pharmacists’ mandatory membership 
within the group. This attempts to ensure 
consistent and appropriate practices in 
pharmacies across Albania.  
 The Ministry of Health is another 
institution that exercises control over the 
pharmaceutical industry, both by setting 
regulations for and by directly monitoring 
the industry. The Ministry wants to “build a 
comprehensive system of traceability (track 
and trace) of drugs in the country” 
(Ministry, 2016). In order to improve the 
traceability, control stamps were 
implemented in 2011 for all drugs imported 
and produced in Albania. In accordance 
with Chapter IV, Article 20 of Law no. 9323, 
these stamps must include the name and 
dosage of the medication, the retail price, 
the ID number of the manufacturer or 
importer, the serial number of the 
reference, and the barcode. The Ministry 
controls the information on these stamps, 
including the prices and dosages, which 
the pharmacies must then follow. 
Figure 10: Ministry of Environment 
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Inspectors are required to visit the 
pharmacies to make sure they are 
following the regulations and laws, but 
there is very little information about how 
frequently the inspections must occur.  
Several laws work together to ensure, at 
least in theory, that pharmaceutical waste 
is disposed of properly. These laws were 
designed to match those of the European 
Union to aid Albania in gaining entrance 
into the EU (Johnson, 2001). The law For 
Hazardous Waste Management (Chapter 1 
Article 4, 2006) states that hazardous 
waste management must be carried out by 
the entity that produced the waste. 
However, the law requires that any who 
dispose of pharmaceutical waste procure a 
license to do so (For Hazardous Waste 
Management, Chapter 4 Articles 12-13, 
2006), and the application process is 
sufficiently demanding that it would not 
realistically be performed by the 
pharmacies themselves. Therefore the 
pharmacies must contract with a treatment 
company that does have the proper 
licenses to dispose of the waste. 
Pharmacies are required to verify the 
license of any third party they contract 
with, keep detailed records of their waste 
and its disposal, and submit 
documentation of the transfer of this waste 
to their regional environmental agency 
(For Hazardous Waste Management, 
Chapter 3 Article 8, 2006). The Ministry of 
Health established a regulatory 
organization, the National Center for Drug 
Control2 (QKKB), which accepts expired 
pharmaceutical drugs from some 
pharmacies, as well as performing other 
regulatory functions in the market. It 
monitors distributions, negotiates with 
manufacturers to lower the prices of name 
brand medications, and seeks to prevent 
                                                 
 
2
 In Albanian, Qendra Kombëtare e Kontrollit të 
Barnave 
shortages of medications (For Medicines 
and Pharmaceutical Services, 2004). The 
QKKB is managed and regulated by the 
Council of Ministers (For Medicines and 
Pharmaceutical Services, 2004, Chapter 3 
Article 12). Manufacturers, importers, and 
distributors of pharmaceuticals are then 
required to give periodical updates of their 
activity to the QKKB (For Medicines and 
Pharmaceutical Services, 2004, Chapter 6 
Article 28). There are a few private 
treatment companies that have the 
certification from the government to 
handle the treatment of medical wastes. 
The list of these companies that we have 
identified can be found in Appendix A. The 
Figure 11: Medi-Tel Treatment Facility 
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three major companies are Medi-Tel, Ilirjan 
& Kadeli and EuroTeam. Medi-Tel is the 
largest of the three, making over 93 million 
lek (740,000 USD) in government subsidies 
during 2015 while Ilirjan & Kadeli and 
EuroTeam made 24 million (190,000 USD) 
and 21 million (166,000 USD) respectively 
(Treasury, 2016). This money is given by 
the government to help hospitals pay for 
the disposal of their hazardous medical 
waste. The treatment companies are 
supposed to take the hazardous waste 
from their contracted suppliers and, 
following the regulations from the 
Ministry of the Environment, properly 
dispose of it. Unfortunately there have 
been some scandals involving these 
waste removal companies. In 2015, one 
treatment company was found to be 
throwing waste from the Berat hospital 
into the Osumi River (Fraud, 2015). In 
addition to the obvious environmental 
destruction this causes, this has the 
serious consequence of weakening the 
credibility of these companies and 
discouraging pharmacies from 
contracting them. 
To summarize the many 
institutions and their connections, Figure 
12  to the right shows the transition of 
pharmaceuticals from production 
through disposal, as well as the different 
enforcement agencies charged with 
regulating the pharmaceuticals.  
As the graphic below shows there are 
often multiple ministries that control a 
both single issue. In the case of 
pharmaceutical waste, the Ministries of 
Health and of the Environment have 
oversight. To complicate the situation 
further both ministries have organizations 
with overlapping responsibilities and the 
ability to make regulations. This leads to 
Figure 12: Institutions involved in regulating pharmaceutical waste (EDEN Center, 2015, Translated for this report) 
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over complication of the legislation, 
leaving the pharmacy owners unsure of 
the current regulations. The national 
government is interested in collaborating 
with “local government bodies, people 
who produce and manage hazardous 
waste, with nonprofit organizations, as well 
as business and professional 
organizations” (For Hazardous Waste 
Management, Chapter 2 Article 6, 2006). 
This collaboration is necessary to create an 
effective regulatory system, but requires a 
careful balance to prevent confusion 
surrounding each jurisdiction and to 
prevent these organizations from 
overlooking improper disposal practices. 
2.7 Pharmaceutical Waste 
Management Challenges in 
Albania 
While there is legislation in place that 
should ensure that Albania meets the 
global standard of pharmaceutical waste 
disposal, there is very little evidence that it 
is being carried out effectively. Though the 
QKKB should receive reports of all 
pharmaceutical waste being created and 
disposed of, there is no public record of 
this waste (National Agency for Medication 
and Medical Devices). Further, the National 
Environmental Agency3 (AKM) did not 
mention the state of pharmaceutical waste 
management in any of their State of the 
Environment Reports over the last half 
decade (AKM, 2011-2015). In the Solid 
                                                 
 
3
 In Albanian, Agjencia Kombëtare e Mjedisit 
Urban Waste section of the 2015 State of 
the Environment Report, the AKM stated 
that the provision of sites for medical and 
hazardous waste was a top priority, 
implying that more work was needed 
(Beqiri, 2015). As the figure above clearly 
shows, Tirana is a crucial location for solid 
waste management. Further, a preliminary 
study conducted by the EDEN Center 
Figure 13: Waste produced by region of Albania (Beqiri, 2015, Translated for this report) 
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suggested that very few of the pharmacies 
they contacted had contracts with 
treatment companies. Our study seeks to 
illuminate this issue and provide data on 
the current disposal practices in Tirana.  
Current literature has limited 
information on the potential causes for this 
possible lack of compliance with 
regulations. One potential factor may be 
the cost of disposal. As noted above, the 
Albanian legislature puts the financial 
burden on the “person who produces 
hazardous waste,” which has been taken to 
mean the pharmacies as the medications 
were not waste when the pharmacies 
received them (For Hazardous Waste 
Management, Chapter 1 Article 4, 2006). 
Such a financial burden can be a major 
disincentive for pharmacies, especially 
smaller pharmacies like those commonly 
found in Albania. Globally, small scale 
pharmacies have compensated for this 
financial strain by charging for returned 
medicines, or through government 
assistance (Jonjic, 2014). Pharmacies may 
also be failing to comply due to a lack of 
training for the pharmacists, especially 
regarding proper disposal methods. 
Although students participate in one 
semester of professional experience 
(Department, 2010), Albanian pharmacy 
students feel that they could benefit from 
more practical work experience before 
they complete their studies. This lack of 
training can lead to improper prescriptions 
and other potentially dangerous mistakes 
(Hwang, 2014). It could also cause mistakes 
that involve dispensing incorrect types or 
amounts of medications, which would 
increase the amount of pharmaceuticals in 
need of disposal, and pharmacists may be 
less likely to follow disposal regulations 
that they do not fully understand. Finally, 
there have been some allegations, as 
noted above, that the treatment 
companies are not trustworthy and may be 
improperly disposing of the medications 
after they receive them from the 
pharmacies (Fraud, 2015). A pharmacy may 
be discouraged from paying money to 
contract with one of these companies if it 
believes that the company is not honest. 
However, none of these factors has been 
directly correlated with the practices of 
pharmaceutical waste disposal in Tirana. 
Our research will attempt to fill the gaps in 
the current understanding of these causes.  
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Chapter 3: Methodology   
The goal of our project was to assess how pharmacies in several neighborhoods of Tirana dispose of expired or unused medications to determine possible 
causes of improper pharmaceutical waste management, and to identify opportunities to improve pharmaceutical waste disposal practices and therefore reducing 
ecological and public health risks due to antibiotic resistant bacteria and endocrine system disruptors. Our objectives were as follows:  
 
 Assess the current practices and policies for pharmaceutical waste management in Tirana; 
 Uncover the challenges that are preventing effective pharmaceutical waste management; 
 Identify stakeholders’ roles and perspectives in the pharmaceutical waste management system; 
 Demonstrate the need for more information on the subject of pharmaceutical waste management; 
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3.1 Assessing the Current Practices in Albania 
We examined the practices of 
approximately 10% of the pharmacies in 
Tirana using a structured questionnaire 
with both closed and open ended 
questions. This 10% is not representative of 
the city as a whole, but is rather selected 
from three neighborhoods. These different 
neighborhoods, as outlined in section 2.6, 
had been selected to vary in their 
demographics and expected levels of 
regulation from the Ministry of Health. The 
expectation was that the neighborhoods 
located closer to the center would be 
regularly visited by the Ministry Inspector 
and would likely be in greater compliance 
with regulations, while more suburban 
neighborhoods would have less oversight. 
It was also expected that neighborhoods 
that were wealthier would be more 
compliant than less affluent areas because 
the pharmacies may be in a better financial 
position to pay for a contract, and their 
wealthier clientele might be more 
concerned with the standards of the 
pharmacy. This research design gave us a 
basis to compare the effect of location and 
affluence on waste disposal practices in 
pharmacies.  
To gather information from these 
pharmacies, we conducted interviews with 
pharmacists and owners of pharmacies 
with the help of volunteers from the EDEN 
Center as translators. We used a multi-
method approach consisting of interviews, 
direct subject observations, and the 
analysis of government and private 
records. These respondents were fully 
informed that all of their answers would be 
kept completely confidential and that the 
information gathered was only intended to 
improve the waste management system. 
This helped to gain the trust of our 
interviewees and increased their 
willingness to share their views. In each 
neighborhood analyzed, we approached 
every pharmacy about participating in our 
study. The questionnaire used for these 
interviews can be found in Appendix B. 
These interviews consisted of questions 
including: 
 Are any medications disposed of by 
this pharmacy? 
 How much medication does this 
pharmacy dispose of? 
 How are these medications disposed 
of? 
 Does this pharmacy have a contract 
with a treatment company?  
This data was compiled and used to 
establish the current state of the 
pharmaceutical waste management in 
Tirana. For narrow questions, like those 
that simply required yes or no answers we 
used a quantitative analysis. For example, a 
binary question like “Does a treatment 
company handle these disposals?” could 
produce a statistic such as “xx% of 
pharmacies have a contract with a 
treatment company.” For the open ended 
questions we conducted a thematic 
analysis (Berg, 2004). Thematic analysis is a 
commonly used qualitative data analysis 
method, and the purpose was to identify 
patterns across a set of data. In order to 
identify these themes and patterns, the 
process consisted of familiarization with 
the data, data coding, and searching for 
themes (About, 2016). We used inductive 
thematic analysis in order to come up with 
trends from the data that we found. After 
each interview, we reviewed and 
summarized the data, and then added 
keywords and tags like “contract,” for 
pharmacies that had contracts, and “no 
companies,” for pharmacies that claimed 
Chapter 3: Methodology 
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there were no treatment companies in 
Tirana. The entire list of keywords and tags 
used to find trends in the data can be 
found in the appendices. This helped us to 
analyze our data by showing us the 
connections and patterns between the 
pharmacies. 
During interviews we also asked the 
pharmacists questions about how often 
the Ministry Inspectors came to the 
pharmacies. This data helped us to see 
how much control the Ministry had over 
the waste management system in Tirana 
demonstrating the relationship between 
the enforcement of and the adherence to 
the law.  
3.2 Obstructions to Proper Waste 
Management  
In our interviews, we identified the 
challenges that were preventing proper 
pharmaceutical waste management in 
Albania. The challenges we investigated 
were cultural, educational, and fiscal in 
nature. We also researched the current 
disincentives that prevent proper waste 
disposal practices. We asked the following 
questions: 
 
 What do you find most challenging 
about following the regulations?  
 What would help to make it easier for 
you to follow the proper disposal 
regulations?  
 What incentives would make the 
pharmacies want to conform to the 
regulations?  
 What recommendations do you have 
to improve the system?  
These questions and the relevant 
interview protocol can be viewed in 
Appendix B. The responses were analyzed 
both quantitatively and qualitatively. As the 
interviews progressed, we noted the 
themes that arose more often and their 
frequency. Open ended questions like 
“What do you find most challenging about 
following the regulations?” could produce 
figures such as “xx% of pharmacies felt the 
regulations were too costly to follow.” This 
allowed us to see the varied perspectives 
of different pharmacists. Further, it showed 
which solutions would be effective for the 
greatest quantity of pharmacies. 
Though we have mentioned that we 
took steps to gain the trust of those we 
interviewed, there were some pharmacists 
that were uncomfortable giving us a 
complete picture of their practices. 
However, their reluctance was still used as 
data, as it is likely that a pharmacist that is 
unwilling to talk to us about their contract 
with a treatment company does not have a 
contract. The responses from these 
interviews provided us data about the 
current practices and sentiments of 
pharmacists in Tirana through which to 
further investigate the causes of these 
practices. 
3.3 Interviewing Additional 
Stakeholders  
We conducted interviews with our 
stakeholders in order to expand our 
understanding of the issues surrounding 
the pharmaceutical waste management 
system in Tirana. We interviewed a 
treatment company representative and a 
distributor. Interviewing the stakeholders 
was important to our study because we 
received information about the system 
from the whole chain of command, not 
just the pharmacies. These organizations 
may further illustrate the current practices 
for pharmaceutical waste 
management and their causes. 
Additionally, they will give us more 
information about their potential to 
influence these practices for the better.  
We interviewed distributors as well, 
which are intermediary companies that buy 
from manufacturers and sell to 
pharmacies, often additionally acting as 
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warehouses for unwanted medications. 
Our interviews included the following 
questions: 
 
 Does your company currently 
manage expired pharmaceutical 
waste? 
 If so, how much? What happens to 
this waste? 
 What is your interpretation of the law 
regarding this disposal? 
 Who do you feel should be 
responsible for paying for the waste 
disposal? 
 
The additional questions can be 
found in Appendix C. Their responses to 
these questions demonstrated the 
perspectives of a commercial organization 
that is responsible for managing expired 
pharmaceutical waste in a similar way to 
the pharmacies. 
A letter was sent to the AKM, 
requesting information on any treatment 
companies they had provided licenses to. 
A list of the treatment companies can be 
found in Appendix D. We interviewed the 
treatment companies that are licensed in 
Tirana, to understand their current 
practices and any challenges they may 
face. We asked questions including: 
 
 How many contracts do you have 
with pharmacies in Tirana? 
 How much waste do you dispose of? 
 How do you dispose of this waste? 
 How do you charge for this service? 
 How do you market your company 
to gain additional contracts? 
 
The response from the treatment 
company about the number of contracts 
and their costs were compared with the 
information provided to us by pharmacists. 
We also used their information about 
marketing, cost, and disposal methods to 
understand the reasons pharmacists might 
not use these companies. Through these 
interviews we expanded our understanding 
of the web of influences surrounding this 
issue.  
3.4 Data Management  
The information collected in our 
study was sensitive, and thus we 
established a protocol to manage the data 
collected. We maintained confidentiality 
for the pharmacy and anonymity for the 
pharmacist during all interviews. We never 
collected personal information about the 
pharmacist we interviewed. We transcribed 
all interviews, and these transcriptions 
were given a code based on the pharmacy. 
A separate corresponding code was used 
to plot the locations of pharmacies on 
maps of the city. To reference between the 
maps and transcripts, we used a grid of the 
code’s correspondences, which was 
deleted at the conclusion of this study. This 
allowed us to track a pharmacy’s location 
without providing specific information 
about responses of that pharmacy. All of 
these separate files were password 
protected. Our transcripts and analyses 
were shared with EDEN through data 
exchange with Jonida Mamaj-Hafizi. 
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Chapter 4: Results   
In this chapter of the report we will discuss the major findings that were a result of the 74 interviews that we performed in Qendra, Ish-Blloku, and Ali Demi. 
In addition to interviews with pharmacies, we interviewed with some of the stakeholders of this project. An interview was conducted with a pharmaceutical 
distributor. We also interviewed a representative of Medi-Tel, a treatment company that works in the Tirana area. The transcripts from these interviews can be found 
in Appendix C. The findings helped to provide insight on the issues in the pharmaceutical waste management system in place in Tirana. The results are organized 
into different sections based off of our original interview questions. Quotations are paraphrased from the translators; the pharmacist originally spoke in Albanian 
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Figure 15 to the left shows the 14 
pharmacies that we interviewed in Ali 
Demi. Ali Demi is the least populated 
district we examined, with the least 
traffic. Figure 16 demonstrates the 
quiet nature of this area. Our study did 
not uncover any pharmacies with 
contracts in Ali Demi, as can be seen in 
Figure 14 below, and the highest 
percentage of pharmacies that refused 
to participate in the study were located 
here. 
 
Figure 14: Sample Ali Demi Street 
Figure 16: Ali Demi Pharmacy Locations and Traffic Levels 
Figure 15: Responses in Ali Demi 
  
 
 
 
 
 
  
As you can see in Figure 17 above, Ish-Blloku has 
26 pharmacies that are spread out with some small 
clusters. Ish-Blloku is one of the wealthier areas within 
Tirana, with very busy streets. An average street in Ish-
Blloku is shown in Figure 18. The responses received in 
Ish-Blloku were varied, as can be seen in Figure 19, but 
most pharmacists did not have a contract despite 
producing pharmaceutical waste. 
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Figure 17: Ish-Blloku Pharmacy Locations and Traffic Level 
Figure 18: Sample Ish-Blloku Street 
Figure 19: Responses in Ish-Blloku 
  
  
The 34 pharmacies in Qendra, shown in 
Figure 22, were located very close together. 
Qendra is very popular with extremely busy 
streets. Figure 20 exemplifies the populated 
streets common in Qendra. This area had the 
highest percentage of pharmacies with a 
contract, and the overall high level of compliance 
is visible in Figure 21. 
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Figure 22: Center Pharmacy Locations and Traffic Levels 
Figure 20: Sample Center Street 
Figure 21: Responses in Center 
  
4.1 Would you be willing to 
participate in our study? 
Almost 20% of pharmacies 
approached to be interviewed 
declined to participate in our 
study. 
When we approached pharmacies, 
we first introduced ourselves and 
described the objectives of our project. 
The pharmacists were given the choice as 
to whether or not they wanted to speak 
with us. Some refused to be a part of our 
study for various reasons. Ali Demi had the 
highest concentration of pharmacists that 
did not want to speak with us, where 29% 
of pharmacists refused. There were a 
variety of explanations for their refusal in 
all of the districts we studied. Some 
pharmacists, primarily located in Qendra, 
felt that they knew the law well enough 
and failed to see the justification of our 
study. Some pharmacists were openly 
hostile towards us; one pharmacist, in 
particular, yelled at us until we left her 
store. Other negative responses we 
received include: pharmacists telling us 
that they did not have time, pharmacists 
telling us that they were too busy, and 
pharmacists acting generally dismissive 
about our questions and our study. 
Another response we received was that the 
pharmacy was new and had opened in the 
past few days, and therefore they would 
not have any information to give us. Many 
times we viewed this information with 
some skepticism, as in previous weeks we 
had seen the same pharmacies running 
while we were mapping out pharmacy 
locations.  
4.2 Do you produce any 
pharmaceutical waste? How 
much? 
About 70% of pharmacies interviewed 
acknowledged that they produce 
pharmaceutical waste, but most 
claimed they produced small amounts 
of waste. 
The vast majority of the pharmacists 
we approached, over 80%, were willing to 
participate in our study. The first question 
asked to the pharmacists was if they 
produced any pharmaceutical waste. A 
significant portion of these pharmacies, 
about 30% of those interviewed, 
responded that they did not. According to 
a pharmacist in Ish-Blloku, it is impossible 
to not produce any waste and “anyone 
who says otherwise is not being honest,” 
which led us to inquire at pharmacies that 
claimed to avoid producing waste how 
they achieved this. One pharmacist said 
that she reduced the price of the drugs as 
their expiration dates approached in order 
to sell them faster. It should be noted 
however, from our interview with Medi-Tel, 
that medications are often imported into 
the country within three months of their 
expiration date. This leaves pharmacists 
very little time to sell the medications, 
causing them to be very careful with the 
amount that they order to make sure that 
waste is not produced. 58% of the 
pharmacies that were interviewed 
acknowledged that they did produce 
pharmaceutical waste. Of those 
pharmacies, many said that they only had 
a small amount of waste. Throughout all of 
the interviews, we found the word “small” 
to mean anything from two to four boxes 
of waste, two to three products, 30 tabs of 
expired medicine per month, or two small 
boxes. Individually these pharmacies 
produce an amount of waste they perceive 
as inconsequential, but may not recognize 
that together the waste adds up to 
significant amounts. 
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“It is the law and 
so we must have 
a contract.” 
-Pharmacist 
 
4.3 Do you have a contract with a 
treatment company? 
Over half of the pharmacies that we 
spoke with admitted to not having a 
contract with a treatment company. 
Of the 60 pharmacies that were 
willing to answer our questions, 18 of them 
said that they did have a contract with a 
treatment company. Our study found a 
number of factors that affected the 
percentage of pharmacies with a contract. 
The location had a large impact on the 
likelihood of the pharmacy having a 
contract. Qendra was the busiest, most 
central area that we analyzed. While 
answers were varied, Qendra had the 
highest percentage, 38%, of pharmacies 
with contracts. In contrast, Ali Demi, the 
least central and least busy district, did not 
have any pharmacies with a contract. From 
this data, the reasonable conclusion can be 
drawn that a pharmacy is more likely to 
have a contract when located in a 
wealthier, more visited part of the city. To 
clarify this, we assigned each street a rank 
based on how busy it was and its relative 
size and traffic. The ranks were determined 
through observations of the foot and 
motor traffic. As the streets get busier the 
percentage of the pharmacies that are 
complying with the laws increases. 
We received a wide range of 
responses as to why the pharmacists had 
decided to get a contract with a treatment 
company. Many explained that they 
wanted to protect the 
environment. Others 
simply did not want to 
be breaking the law. 
While the reasoning 
behind why some 
pharmacists have a contract is important, 
our study focused primarily on the 
responses of those without one.  
Over half of the pharmacies in our 
study admitted to not having a contract 
with a treatment company. This 56% can 
be divided into two major 
categories; 23% claimed to 
have no waste at all and 
therefore had no need for a 
contract and 33% who have 
waste but did not have a 
contract. Many of the 
Figure 23: Responses by Traffic Level 
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“I already lost money 
from not being able to 
sell the medicine so I 
cannot afford to pay for 
their disposal as well.” 
-Pharmacist 
 
pharmacies that claimed to produce no 
waste were dismissive, and less interested 
in discussing the challenges of proper 
disposal. The group that did have waste, 
but did not have a contract, provided 
insightful responses and reasons for not 
using a treatment company and from 
these we have been able to identify the 
flaws in the waste management system.  
 
The small size of the pharmacies makes 
them less likely to comply with the law.  
Half of the pharmacists we spoke 
with mentioned that they had very small 
amounts of waste. The majority of the time 
this was used to demonstrate that they did 
not need to have a contract because they 
believed they could just throw away or 
otherwise dispose of the small amount of 
waste that they had without making a 
large environmental impact. The 
pharmacies may not be able to see the 
impact that their relatively small amounts 
of waste has on the environment or the 
cumulative damage caused by many 
pharmacies all behaving this way.  
The cost of treatment can be 
prohibitive. 
Cost was another pervasive influence 
on pharmacy owners. The two most 
common prices mentioned to us for 
treatment were annual fees of either 6000 
or 12000 lek (46.99 or 93.98 USD). Some 
pharmacies also mentioned a security 
deposit of 6000 lek. Finally pharmacists 
mentioned being charged by quantity of 
waste to be removed. One mentioned 
paying 400 lek/kg (1.42 USD/lb), while 
another mentioned paying the value 
added tax (V.A.T.) of 2% of the price of the 
expired medications. The treatment 
company we interviewed, Medi-Tel, 
showed us contracts where they charged 
20 Euros (22.60 USD) annually, 500 lek/kg 
(1.76 USD/lb), and the 2% V.A.T. Concerns 
about cost may be a legitimate expression 
of pharmacies’ inability to pay, rather than 
a complaint. Most of these pharmacies are 
individually owned, as opposed to large 
chain companies or those with many 
investors, which limits their capital 
resources. This lack of capital means they 
may not be able to front the yearly cost of 
disposal. Further, the control of the 
wholesale price by the Ministry limits the 
profit margins and therefor the flexibility of 
pharmacy budgets. Therefore many 
pharmacies seemed justified when they 
said that they did not have a contract due 
to its price.  
 
Obtaining contact information for the 
treatment companies is a barrier for 
pharmacies.  
A quarter of the pharmacists 
interviewed either could not find a 
treatment company or believed that none 
existed. This meant that they were unable 
to follow the regulations, assuming they 
wanted to. Additionally, during our own 
extensive research we could not find 
contact information for a majority of the 
treatment companies. After receiving the 
response from the Environmental Agency, 
we were given a list of 10 different 
treatment companies that have 
environmental licenses. We then tried to 
find any form of contact information for 
these companies but our successes were 
limited. This supported the pharmacists 
that claimed they could not locate 
information about treatment companies.   
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“To get a contract I 
would have to call 
multiple ministries.” 
-Pharmacist 
However, when we interviewed a 
representative from Medi-Tel, he believed 
his information was easy to find, especially 
when looking on the website for the 
National Center of Business. He implied 
that pharmacies were likely to claim that 
they did not know of any companies to 
justify avoiding contracts. However, 
pharmacies that did 
have contracts also 
claimed that they had 
experienced difficulty 
contacting a company. 
Further, our own 
experiences suggest 
that even with the National Center of 
Business, some companies remain difficult 
to find. If the treatment companies 
marketed themselves better, they could 
drastically increase their own business and 
reduce the amount of improperly disposed 
of waste. Alternatively, Medi-Tel believes 
that more Ministry control and oversight 
would encourage more contracts with 
pharmacies. Whether it comes from the 
treatment companies or the Ministry, 
pharmacists would benefit from more 
information about the available treatment 
companies. 
A lack of trust in the treatment 
companies is a significant barrier. 
Many pharmacists responded that 
they do not trust treatment companies to 
properly dispose of the waste. A quarter of 
the pharmacies interviewed in Ish-Blloku 
mentioned that they do not believe the 
treatment companies 
are properly 
disposing of the 
medicines, but 
instead are simply 
throwing them away. 
This idea has very 
important 
implications. Pharmacists who distrust the 
companies have no motivation, other than 
blind compliance with the law, to contract 
with a treatment company. A lack of trust 
is a significant barrier that will have to be 
overcome to establish an effective waste 
disposal system.  
Some believe pharmacists may not 
need contracts, as they can return their 
waste to a distributor.  
A few pharmacists mentioned that 
they did not have a contract because they 
could simply send their waste to a depot. 
This was confirmed by the Medi-Tel 
representative when he said that the law 
states that all pharmacies should be able 
to return their expired medication. It was 
also mentioned by the distributor we 
interviewed, who stated that a pharmacy 
should never have a contract, as they can 
always return waste to the distributor free 
of charge. He stated this with complete 
assurance, but among 60 interviews we 
only found two pharmacies that said that 
they returned their waste to a depot. 
Pharmacists have no reason to lie about 
this, if this option is as easy and legal as 
implied. This seems to support the 
assertion that there is inconsistent and 
limited information available to 
pharmacists and other stakeholders in the 
pharmaceutical waste management 
system. 
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4.4 How often does the inspector 
come? 
Pharmacists have trouble relying on the 
inspection system. 
During our interviews, we asked the 
pharmacists how frequently the inspectors 
came to the pharmacies each year. Figure 
25 below shows the frequency of inspector 
visits per year for 48 different pharmacies 
varied.  
The number of visits ranged between 
0-12 times per year, and responses were 
very inconsistent, with many pharmacists 
giving us a range of possible frequencies. 
One pharmacist mentioned that the 
inspectors were very unscheduled and 
would come “maybe once a year, maybe 
three times a week.” Pharmacists have 
trouble relying on the inspection system. 
Through our interviews, we found that 
there was a 
relationship between 
the number of 
inspector visits per 
year and whether or 
not the pharmacy had 
a contract or waste.  
Table 2 is a heat map 
that shows the 
relationship between 
the number of 
inspector visits to a 
pharmacy per year 
(ranked between 0 and 3+)4 and if the 
pharmacy has a contract and/or waste. 
This figure shows the correlation between 
the frequencies with which the inspectors 
visit and the responses they provided 
about their disposal practices in the 
pharmacies that responded to this 
question. Pharmacies that told us about 
their inspector visits either had a contract 
(Has Contract), did not have a contract but 
did admit to producing waste (Produced 
Waste), or claimed they did not produce 
waste, and therefore did not have or need 
to have a contract (No Waste).  
                                                 
 
4
 If we receive an answer with a range of 
values, it went with the lower of the two values. 
 
Table 2: Heat Map of Responses by Frequency of Inspectors 
Figure 24: Frequency of inspector visits 
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“No one provides 
information about 
the laws and 
regulations.” 
-Pharmacist 
 
“We feel very 
uninformed 
about the laws” 
-Pharmacist 
 
“There is no one 
enforcing the laws so 
we have no need to 
follow them.” 
-Pharmacist 
 
The color code in the heat map is used to 
show the different percentages of 
pharmacies that fit into the category based 
on the number of inspector visits they had 
per year. The darker the green in each box, 
the higher the percentage. For example, of 
all the pharmacies that said they saw the 
inspector annually, 63% did not have a 
contract with a treatment company but 
had waste. Since the 63% is a higher 
number compared to the other numbers, 
the box is a darker 
green color. 
Percentages are 
displayed to 
normalize the 
different sample 
sizes. This heat 
map was created 
with the 
percentages of the pharmacies that were 
inspected a certain number of times. Each 
column therefore totals 100%. This was 
selected because not all pharmacies 
responded about their inspection 
frequency and 100% would not have been 
reached. This heat map helps to show that 
the number of inspector visits did seem to 
contribute to a higher percentage of 
pharmacies that had a contract with a 
treatment company.  
4.5 Do you understand the laws? 
Pharmacists were lacking information 
about the laws and regulations that 
they must be following.  
According to Law No. 9323 “On 
Medicines and Pharmaceutical Services” 
Article 4, producers of hazardous waste 
must have an environmental license in 
order to dispose of the waste. This is why 
pharmacies use treatment 
companies. We found that 
pharmacists lacked 
information about the laws 
and regulations that they 
must be following, which 
makes it very hard for them to 
comply. We received many 
different answers from the 
pharmacists about the laws. Some 
pharmacists claimed they knew and 
followed the law, while others claimed that 
they had not been given enough 
information. In both cases, we found that 
not all of pharmacists were following the 
laws, even if they knew the provisions. 21 
out of the 74 pharmacists that were 
interviewed claimed that they were 
confused 
or lacked 
knowledge 
about the 
laws and 
regulations 
regarding 
pharmaceutical waste.  
While some pharmacists were aware 
that they did not know the laws, some 
claimed to know the laws. About one in 
three of these did not seem to be acting in 
accordance with the law. One pharmacist 
said that she dug a hole in the ground and 
then deposited the expired drugs in that 
hole. She then mentioned that she knew 
the law, even though she said that she did 
not need a treatment company to take 
care of the expired drugs. A few 
pharmacies said they are following the law 
but they do not have a contract for the 
waste they acknowledged producing. 
Therefore, we can infer that they do not 
completely understand the laws or they do 
not want to follow them.  
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“We feel like we’re 
losing lots of money 
because we follow the 
law.” 
-Pharmacist 
 
“Pharmacists do not 
want to break the law, 
but are forced to by 
the cost of 
complying.” 
-Pharmacist 
 
4.6 What do you find 
challenging? 
Pharmacists varied in their willingness 
to participate in this section of the 
interview.  
Pharmacists in Ali Demi were very 
willing to discuss their challenges and 
recommendations with us. While fewer 
pharmacists were interested in 
participating in the interview than those in 
other neighborhoods, those we did speak 
with were much more receptive. They were 
frustrated by the lack of help and 
information they received, and appreciated 
our attention and interest in improving 
their businesses. Their concerns will be 
discussed in greater detail below, as will 
those of each district.  
In contrast, many of 
the pharmacists we spoke 
with in Qendra were less 
interested in discussing 
the challenges they 
faced. Many did not feel 
the need to make any 
recommendations they 
had. Several claimed to 
be well informed, well 
behaved, and thus did 
not need to speak to us further. In general, 
they seemed unreceptive to the idea that 
someone like us would be coming around 
to help them, and about one in five of 
those we talked to seemed hostile, rude, or 
dismissive.  
 
Many pharmacists felt that the cost of 
disposing of pharmaceutical waste 
properly was a significant disincentive.  
Depending on the 
company, pharmacists can 
get charged annually and 
per weight of the waste 
treated, often with an 
additional security 
deposit. It was 
comparatively more likely 
for Ish-Blloku pharmacists 
to worry about the cost of the contracts, 
but it was a recurring 
sentiment in all 
areas. Pharmacists 
expressed that they 
could not pay for the 
waste removal, since 
the expired 
medication already 
represented a loss of 
income. Many felt 
that, given the small 
amount of waste they produce, it was not 
in their best interest to pay annual fees for 
a contract. Pharmacists reported crushing 
some of their waste to reduce the cost of 
disposal. The pharmacies in our study were 
small and over 90% were independently 
owned, rather than being a part of a chain, 
which makes the costs of obeying the law 
more onerous and unappealing. One 
pharmacist suggested that the government 
should offer tax cuts for disposing of 
pharmaceutical 
waste, and 
many expressed 
that they would 
appreciate more 
financial 
assistance. For 
pharmacists to 
comply with the 
laws they must have adequate financial 
resources.  
However the increased cost of 
environmental protection is something 
that the pharmacies may need to foot 
despite their initial discomfort. The 
environment is a shared resource that all 
must work to protect. There is a long 
precedent of regulation to protect the 
environment hurting business at first but 
benefiting society in the long run 
(Matheus, 2015). So while pharmacists may 
have expressed concerns with the costs, 
Chapter 4: Results 
Chapter 4: Results Chapter 4: Results 
  
“The government is 
not here to help us.” 
-Pharmacist 
 
“[The Ministry] doesn’t 
distribute the rules and 
regulations well, the 
companies must keep up 
with what they do.” 
-Distributor 
these complaints may just be an 
unavoidable part of environmental 
regulation.    
   
Many pharmacists would appreciate 
more guidance and assistance from 
their government.  
The Ministry of Health is in place to 
set regulations for and monitor the 
pharmaceutical industry, but many 
pharmacists feel that they are not getting 
enough help from the Ministry. Some 
pharmacists even said that they felt the 
Ministry was not motivated to make the 
process easier. A few of the pharmacies 
that had been open for less than a year 
said that they were waiting for the Ministry 
to come tell them what to do with their 
waste. They assumed that eventually 
someone 
would 
come and 
help them, 
but had 
not seen 
anyone yet. One pharmacist chose not to 
participate in our recommendations 
portion of the interview because she felt it 
would be pointless. She said that she had 
brought her recommendations to the 
Ministry of Health and to the Order of the 
Pharmacists and 
no one had taken 
her seriously. 
“Nothing is going 
to be done,” she 
told us. 
Interactions like 
these left her and 
some of the other 
pharmacists with 
the impression that they could not use 
these institutions for support.  
4.7 Challenges Expressed by 
Additional Stakeholders  
Distributor 
The distributor we interviewed also 
experienced difficulties with the 
pharmaceutical waste management 
system. Our contact explained that his 
distribution company would take the 
expired medicines back free of charge 
from the pharmacies, but that this 
happened very rarely because he 
would accept and fill orders daily. He 
informed us that after years his company 
had accumulated a large stockpile of 
pharmaceutical waste, and that he was 
waiting for a cheaper way to dispose of it. 
This practice of stockpiling medications 
may not be isolated; in our interview with a 
Medi-Tel representative 
he suggested that 
hospitals within the city 
could be accumulating as 
much as 20 tons of 
expired pharmaceutical 
waste without any clear 
intentions to dispose of it 
properly. The distributor 
we interviewed chose to 
stockpile his waste because he believed 
there was only one company that was 
currently treating such waste and felt that 
meeting the price they charged would 
significantly impact his business. He 
lamented that he had to take such financial 
risks when purchasing inventory and incur 
heavy disposal costs if they did not pay off.  
This distributor expressed the 
challenges he had encountered with the 
Ministry of Health and other government 
institutions. He felt as though the process 
to declare waste to the government and 
report its transfer to a treatment company 
was time consuming and demanding. He 
also felt as though the various Ministries 
had the responsibility to enforce the laws, 
and suggested that the Ministry should 
take a more active role in this 
enforcement. 
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“[The QKKB] has 
their own waste, 
they cannot take 
care of other waste.” 
-Treatment Company 
 
 
Treatment Company  
The treatment company 
representative we interviewed saw various 
opportunities to manage pharmaceutical 
wastes more effectively. He claimed that 
many of the 
other treatment 
companies 
were dishonest, 
and publicity 
surrounding 
this tarnished 
the reputations 
of other 
treatment companies, including his 
company Medi-Tel. He was very eager to 
be transparent with their practices, as he 
felt that pharmacies would not be likely to 
get contracts with treatment companies 
they found suspicious.  
He also said that from his perspective 
the government did not adequately 
enforce the laws concerning pharmacies. In 
our interview, he asked where the 
pharmacies we had spoken to send their 
waste, and we mentioned that, among 
other institutions, some pharmacies send 
their waste to the QKKB. The Medi-Tel 
representative claimed that the QKKB, as a 
national organization, was not the proper 
institution to be taking care of the waste. 
Rather, in his opinion, it should focus on 
enforcement of regulations. He believes 
that even this government institution is not 
working correctly because there is limited 
information concerning the business 
practices at the QKKB. Medi-Tel 
only has 4 contracts with 
pharmacies, but he stated that 
“the government is not pushing 
pharmacies to follow the 
regulations, and with more 
enforcement the system would 
work.” Although he is not out 
actively seeking contracts with 
pharmacies, he believes that the 
pharmacies will begin searching for his 
company when there is more enforcement.   
  Chapter 4: Results 
Chapter 4: Results 
  
Chapter 5: Recommendations 
Improving Access to Information 
The most prevalent issue that we 
found was the lack and inconsistency of 
information provided to pharmacists. We 
believe that pharmacists would benefit 
tremendously from knowing specifically 
which laws they are expected to adhere to. 
It would also be helpful to inform 
pharmacists how they can get in contact 
with treatment companies, so that the 
process can be as simple as possible. 
Finally, it would be important to include 
information about why it is important to 
follow these laws, as well as the 
environmental impact of even a small 
amount of pharmaceutical waste, which 
could be distributed to pharmacists and 
pharmaceutical students. A possible way to 
distribute this information would be to 
create a fact sheet or pamphlet to 
distribute to pharmacies. This would give 
pharmacists the information they need to 
effectively contract with a treatment 
company.  
Frequent and Consistent Regulations  
Additional steps that may help 
improve pharmaceutical waste 
management include increased oversight 
from the ministry. This increased oversight, 
e.g. more frequent and consistent visits 
from a Ministry of Health and Environment 
inspector, may make pharmacies feel that 
there are greater consequences for not 
complying with the regulations. In 
addition, it could provide an opportunity 
for the pharmacists to ask any questions 
they may have regarding the laws or 
treatment companies.  
 
Incentives for Proper Waste Disposal 
Another method to positively impact 
the current waste management system 
would be to establish incentives for 
complying with the law. Incentives that 
could improve the disposal practices of 
pharmacies include financial subsidies, tax 
cuts, or even the opportunity to advertise 
to customers that their pharmacy is 
environmentally friendly. Previous attempts 
at regulating this industry have shown that 
incentives have been an effective way to 
increase compliance, because pharmacies 
must have adequate resources to comply.    
Further Investigation 
The data that we collected was highly 
variable, and revealed many questions 
about the current system. Our study was 
limited in its scope, and the pharmacies we 
interviewed were not representative of the 
city, not to mention the country as a 
whole. We have also seen some 
inconsistencies in the responses we 
received. Examples include varied opinions 
about returning waste to the distributors, 
the regulatory role of the government, and 
the availability of information to the 
pharmacists. Additionally, it would be 
beneficial to analyze the practices and 
perspectives of the relevant government 
bodies.  
While we have been able to outline 
major recommendations that could 
improve the system as it currently stands, 
more options could be identified and 
analyzed. A study with greater resources 
and authority will be better able to 
investigate all of the stakeholders involved. 
Our final recommendation is that these 
issues be studied further.  
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Appendix A 
List of Treatment Companies 
EuroTeam 
EcoTeam 
Hygeia Hospital 
Iridiani 
V.A.L.E. Recycling 
Medi-Tel 
3 P Life Logistic 
SaniService 
Kneo Transport Kompani 
Elkiri & Company 
  
  
Appendix B 
Interview Protocol 
Considerations:  
 When requesting the interview we asked the pharmacist if 
they were willing to have an interview with us. This was done 
by the translator, and the interview proceeded in Albanian if 
the pharmacist was willing. 
 Interviews took place in the pharmacy. 
 We interviewed pharmacy owners and pharmacists.  
Biases 
 We remained neutral in our questions, so the respondents did 
not feel pressured to give us the answer we want.  
 We asked mostly open ended questions, instead of pointed 
questions that lead to one particular answer. 
Lying 
 We told them that this interview is completely anonymous. 
 We told them that we are trying to help improve the country 
and environment. 
Validity 
 We interviewed all pharmacies in each neighborhood. 
 Quasi Statistics were used to turn qualitative data into 
quantitative data. 
  
  
Interview with Pharmacists 
Date: 
Time: 
Location: Pharmacy 
Attendees: 
Introduction:  
We are American students doing research on the question 
of how pharmaceuticals are disposed. We are assisting the Eden 
Center, which studies environmental issues in Albania in the hopes 
of resolving them. We just wanted to let you know that what you 
tell us in the interview will be confidential, can be anonymous, and 
we are simply trying to collect data for our report. We will not 
identify you by name in any of the reports using any of the 
information obtained from this interview, and your confidentiality 
in this study will remain secure. This study is intended to 
understand what is currently happening in the city as a whole so 
that we can help, and we would be thankful for as much accurate 
information as you can provide.  
If there are any questions that you do not want to answer, 
just let us know and we will move on to a different question. 
Before we begin the interview, do you have any questions for us? 
Questionnaire: 
 Do you have pharmaceutical waste? How much waste do 
you produce per week? 
 Do you have a contract with a treatment company? Which 
company do you have a contract with? How long have you 
had this contract? How much does it cost you to manage 
your waste? Where does your waste go? (Incineration, 
storage, throw away) 
 How often does the inspector come to the pharmacy? 
 What do you find most challenging about following the 
regulations? What would help to make it easier for you to 
follow the proper disposal regulations? What incentives 
would make the pharmacies want to conform to the 
regulations? What recommendations do you have to 
improve the system?  
 Is there anything else you would like to talk about, or is 
there any information we can provide?  
 At the end of the interview, we thanked the pharmacist for 
their time. 
 
 
 
  
  
Appendix C 
Interview with Distributor 
Location: Apartment  
Date: 12/12/2016 
Time: 9:00 PM 
Attendees: Distributor, Students 
Introduction: 
We are American students doing research on the question 
of how pharmaceuticals are disposed. We are assisting the Eden 
Center, which studies environmental issues in Albania in the hopes 
of resolving them. This study is intended to understand what is 
currently happening in the city as a whole so that we can help, and 
we would be thankful for as much accurate information as you can 
provide.  
If there are any questions that you do not want to answer, 
just let us know and we will move on to a different question. 
Before we begin the interview, do you have any questions for us? 
 
 
 
 
 
 
 
Questionnaire: 
 Do we have permission to record this, can we quote you 
in our paper?  
 
 Who does your company distribute to? 
 
 What happens with expired drugs? 
 
 What is your interpretation of the law? 
 
 How did you find this information? Do you feel it was 
easily accessible? 
 
 Do you feel that the pharmacy should be responsible for 
contracting with a treatment company? 
 Who should be responsible for paying for the waste 
disposal? 
 
 How do you feel about the role of the government in 
this process? 
 
 Do you have any recommendations for the system in 
place? 
 
 Can you think of anything important that we should 
know?  
  
Interview with Treatment Company  
Time: 9:00 AM 
Date: 12/12/16 
Location: Medi-Tel Facility  
Attendees: Eden Employee, Students, Medi-Tel Personnel  
Disclaimer: All Answers are translated from the original Albanian  
Introduction:  
We are American students doing research on the question 
of how pharmaceuticals are disposed. We are assisting the Eden 
Center, which studies environmental issues in Albania in the hopes 
of resolving them. We just wanted to let you know that what you 
tell us in the interview will be confidential, can be anonymous, and 
we are simply trying to collect data for our report. We will not 
identify you by name in any of the reports using any of the 
information obtained from this interview, and your confidentiality 
in this study will remain secure. This study is intended to 
understand what is currently happening in the city as a whole so 
that we can help, and we would be thankful for as much accurate 
information as you can provide.  
If there are any questions that you do not want to answer, 
just let us know and we will move on to a different question. 
Before we begin the interview, do you have any questions for us? 
 
Questionnaire: 
 
 Can we record this and use it our our report? 
 
 How many contracts do you have? 
 
 How many times do you pick up the waste? 
 
 How do you treat the waste? 
 
 Are you aware of the laws? 
 
 How is it with other companies? Is it competitive? 
 
 How do you market your company to get more 
contracts? 
 
 Do you have a register for the waste? Can we see it? 
 
 How much do you charge for this service? 
 
 Is there anything else you want to tell us? 
 
 
  
  
Pharmacy Contract    
  
0
2
4
6
8
10
12
14
Refused
Interview
No Waste Waste No
Contract
Contract
Response by Location 
Ali Demi Ish-Blloku Center
Appendix D 
 Detailed table of responses broken down by location 
and other factors 
 In addition to analyzing the interviews for themes and 
opinions from pharmacists, we sorted the data into relatively 
simple categories. The first of these was for those who refused to 
participate in our interview, which was shortened to Refused 
Interview. Next were those that claimed they did not produce any 
waste, or No Waste. All pharmacies we interviewed that claimed 
they did not produce any waste also said they did not have a 
contract. Some admitted to having waste but still did not have a 
contract, referred to as Waste and No Contract or W/NC. Finally, 
all those that had contracts also said they had waste, though in 
varying amounts, and were grouped into a final category of 
Contract. For quantifying purposes, these were given values of 0, 1, 
and 3 respectively, so that ‘averages’ as well as other data could 
be determined.  
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Code Definition Number of Pharmacies 
FC No treatment companies exist, or they were/are hard to find 11 
Cost Company cost too much money, cost could be an important factor in getting a contract 9 
Trust The pharmacy does not trust the treatment company 5 
QKKB This pharmacy had a contract with the QKKB  7 
ET This pharmacy had a contract with EuroTeam 3 
Trash Throws/ed expired drugs into the trash 6 
Sewer Flushes/ed expired drugs down the toilet 4 
Manuf Returns the drugs to their manufacturer 1 
Depot The drugs are given to drug depots or warehouses 2 
Law There (is) are no (enforcement of the) laws in place 11 
Confused They are confused about the laws in place or don’t know anything about the law 21 
Wrong Believe they know the law/are following it when they don’t/aren’t 4 
Info Say they are (and appear to be) informed about the law 8 
Small If they mention that they are a small pharmacy 1 
Little Small amounts of expired drugs from the pharmacy 28 
0 Would not speak to us 14 
1 Denies producing waste 17 
  
  
2 Produces waste but doesn’t have a contract 24 
3 Produces waste and has a contract 19 
Angry The pharmacists was dismissive, angry, no time, etc 16 
New The pharmacy was new, therefore won’t have much waste or don’t have their contract yet. 7 
Help They are interested in help, want more from government 13 
Nohelp Don't need anything/help 4 
Nodif We don’t have any difficulties  6 
 46 
 
Chart of Responses by Neighborhood
 
  
By Unit Ali Demi = 14 Blloku = 26 Qendra = 34 Total = 74 
Refused Interview 4 = 28.9% 6 = 23.1% 4 = 11.8% 14 = 18.9% 
No Waste  4 = 28.9% 3 = 11.5% 9 = 26.5% 17 = 23% 
W/NC 6 = 42.9% 11 = 42.3% 8 = 23.5% 25 = 33.8% 
Contract 0 = 0% 6 = 23.1% 13 = 38.2% 19 = 25.7% 
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Appendix E 
Busyness ranking  
 
1: Busiest 
This is a picture of a street in Qendra, it is 
very busy both in terms of foot traffic and 
motor traffic, which is why it received a 1 
on our traffic level scale. 
 
2: 
This is a picture of Sami Frasheri in Ish-
Blloku. This street receives a lot of foot 
and motor traffic, but not as much as 
others, so it received a 2 on our traffic 
level scale. 
 
3:  
This is a picture of a street in Ish-Blloku. 
This street is moderately sized with a 
moderate amount of traffic and was given 
a 3 by our traffic level scale. 
 
 
4: 
This is a picture of a street in Ali-Demi. 
This street has small amount of traffic 
and received a 4 on our traffic level scale. 
 
 
5: Quietest 
This is a picture of a small side street in 
Ali-Demi. This street received very little to 
no foot and motor traffic, which is why it 
was given a 5 on our traffic level scale. 
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